跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 121 条关于
“Allarity”
全部
121
临床试验
58
药物
5
机构
8
资讯
50
去年
Allarity Therapeutics' Stenoparib Shows Promise in Advanced Ovarian Cancer Phase 2 Trial
去年
Allarity Therapeutics Advances Stenoparib for Ovarian Cancer with Phase 2 Trial Expansion
去年
Allarity Therapeutics Unveils Novel Predictive Tool for Daratumumab Response in Multiple Myeloma Patients
7个月前
Allarity Therapeutics Opens Phase 2 Trial Combining Stenoparib with Temozolomide for Relapsed Small Cell Lung Cancer
去年
Allarity Therapeutics Receives FDA Fast Track Designation for Stenoparib in Advanced Ovarian Cancer
11个月前
CHOSA's Platinum Drug Predictor Shows Promise Across Multiple Cancer Types in Clinical Validation Studies
9个月前
HER2-Negative Breast Cancer Pipeline Expands with 75+ Therapies from 70+ Companies
去年
CHOSA's Platinum Drug Response Predictor Shows Promise in Personalizing Cancer Treatment
去年
Clarity Pharmaceuticals Initiates Phase I/IIa Trial of 64Cu-SAR-bisPSMA for Metastatic Castration-Resistant Prostate Cancer
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA Gain FDA Fast Track Designations for Prostate Cancer
第 1 页,共 5 页
上一页
下一页